General Information of DTT (ID: TT6AXLY)

DTT Name Leucine-rich repeat kinase 2 G2019S mutant (LRRK2 G2019S) DTT Info
Gene Name LRRK2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Patented Agent(s)
4 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aminopyridine derivative 3 DMSLJE8 N. A. N. A. Patented [1]
Oxindole derivative 3 DM0ENF3 N. A. N. A. Patented [1]
Oxindole derivative 4 DM3U58I N. A. N. A. Patented [1]
Pyrrolo-pyridine derivative 2 DMVNY5I N. A. N. A. Patented [1]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-2016).Expert Opin Ther Pat. 2017 Jun;27(6):667-676.